Transitioning Your Dental Practice to a DSO: 8 Steps

Key Takeaways

• DSO affiliation means selling all or part of a dental practice to a Dental Service Organization in exchange for cash, rollover equity, and potential earnouts, usually under a multi-year employment agreement.

• A structured sell-side process with competitive bidding can meaningfully improve deal outcomes, with McLerran & Associates achieving 85–90% close rates versus an industry norm of 35–40%.

• Preparation is critical. Owners benefit from assembling a sell-side team, preparing 3 years of clean financials, and obtaining an independent CPA-led EBITDA valuation before engaging buyers.

• Key deal variables include cash at close (often 50–80%), rollover equity (up to about 40%), and earnout structures that require careful negotiation to protect seller interests.

• Whether you are 6 months or 3 years from a transition, schedule a free, confidential discovery call with McLerran & Associates to understand your options and protect your valuation before speaking with any buyer.

Why a Structured Sell-Side Process Matters for Dentists

A practice owner usually sells once in a lifetime, while a DSO negotiates acquisitions every week. That imbalance can be one of the main reasons sellers leave money on the table.

Without a structured process, an owner often receives a single inbound offer, accepts the buyer’s view of value, and negotiates without competitive tension. A competitive auction process that invites indications of interest from multiple DSOs and qualified private buyers at the same time can improve both price and terms compared with a single-bidder process that starts with an inbound DSO call. Do-it-yourself close rates can run as low as 15–20%, compared with roughly 80% for a well-run brokered process.

McLerran & Associates has guided owners through roughly 2,000 successful practice sales totaling about $2 billion in closed transaction volume, with a transaction rate of roughly 85–90% compared with an industry norm closer to 35–40%. That performance gap can be tied to process: a CPA-led EBITDA analysis completed before the deal goes to market, a vetted buyer pool, and a structured competitive bid process that often generates about 10 offers within 45–60 days.

U.S. DSO affiliation among dentists has grown from 7.2% in 2015 to over 30% under broader definitions that include joint-venture and partnership structures, and dentistry is currently about one-third consolidated. Demand for premier, Class A practices remains strong, and owners who capture the most value usually follow a clear, disciplined roadmap that matches the rigor buyers bring to the table. That rigor begins with a structured, step-by-step plan.

The 8-Step Roadmap to a Successful DSO Transition

The following 8 steps outline the framework McLerran & Associates uses to guide practice owners from early planning through a successful close.

1. Clarify your goals and your “why.” Start by identifying what is driving the decision, such as taking chips off the table, reducing the burden of running a large organization, funding growth, or planning an eventual exit. Your “why” shapes which deal structure and which buyer can align with your clinical, financial, and lifestyle goals.

2. Assemble your sell-side team. A dental-specific sell-side advisor, a CPA experienced in dental mergers and acquisitions, and a healthcare attorney should be in place before any buyer conversations begin. Each advisor brings different expertise: the advisor manages process and negotiation, the CPA builds and defends your financial analysis, and the attorney focuses on legal terms and risk. Together they protect your interests, while the buyer relies on its own team to protect theirs.

3. Prepare 3 years of clean financials and key metrics. Sellers can benefit from preparing financials 6–12 months before going to market, because clean monthly history cannot be created the week before a letter of intent. Gather 3 years of tax returns, profit-and-loss statements, and practice management software reports covering production, collections, active patients, and provider mix.

4. Obtain an independent, CPA-led EBITDA valuation. EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization, and it is the profitability metric DSOs commonly use to price practices. A CPA-led analysis reviews every discretionary, personal, and non-recurring expense (often called “add-backs”) to arrive at normalized profitability. Undocumented or aggressive EBITDA add-backs are a frequent source of disputes in diligence, and each challenged adjustment can reduce valuation by the add-back amount multiplied by the purchase multiple. A diligence-grade valuation completed up front can be one of the strongest protections against a deal being re-traded later.

5. Build marketing materials and a virtual data room. A professional marketing deck presents the practice’s story, financials, and growth opportunity in a clear, concise format. A virtual data room, which is a secure and organized online folder of financial, operational, and legal documents, allows vetted buyers to review information efficiently and signals that the seller is serious and prepared.

6. Run a 45–60-day competitive bid process among vetted buyers. Soliciting offers from multiple well-qualified, pre-vetted buyers at the same time creates competitive tension that can move both price and terms in the seller’s favor. Poorly run or undercapitalized buyers should not reach the table. At least 175 dental practice locations were sold to DSOs, private equity groups, and other buyers in the first half of 2026 alone, so the buyer pool is active, although not all buyers offer the same strength or reliability.

7. Negotiate LOI terms: cash, equity, and earnouts. The Letter of Intent (LOI) is the non-binding term sheet that outlines the main business points of the deal. Key variables include cash at close, which is the percentage paid immediately at closing, rollover equity, which is an ownership stake in the DSO platform, and earnout provisions, which are future payments tied to post-close EBITDA or production targets. Equity rollover allows the seller to participate in a second exit when the platform itself sells, often in 3–7 years. Earnouts are most commonly measured over 12, 24, or 36 months. Non-punitive structures, such as pro-rata provisions that pay a proportional amount even if a target is narrowly missed, are worth negotiating clearly.

8. Defend quality of earnings and close. After the LOI is signed, the buyer’s team conducts a Quality of Earnings (QoE) review, which is an independent financial analysis that stress-tests the seller’s adjusted EBITDA. Sell-side QoE reports typically reduce the seller’s stated EBITDA by 10–30%. A sell-side advisor who built the original EBITDA analysis can defend each add-back, remind buyers that other vetted bidders remain interested, and help prevent the deal from being re-traded near the finish line.

Schedule a free, confidential discovery call with McLerran & Associates after Step 4, before a buyer’s valuation sets the anchor for your negotiations.

Comparing DSO and Private Equity Buyer Types

DSO transactions can take several forms, and each structure carries a different mix of cash at close, equity rollover, and valuation range. The table below summarizes major deal types based on current market data. All figures are ranges, and actual outcomes can depend on practice size, profitability, specialty, and location. Dentists can benefit from consulting advisors before drawing conclusions from any single data point.

Deal Type	Cash at Close	Equity Rollover	Typical Multiple Range (EBITDA)
Formal DSO Acquisition	65%–75%	20%–30%	6x–9x
Regional Roll-Up	70%–80%	Lower; varies by deal	5x–7x
Platform PE Acquisition ($3M+ EBITDA)	60%–70%	Significant; varies by structure	9x–13x
IDSO Partnership (partial equity sale)	50%–65% of portion sold	Seller retains brand equity	8x–11x on equity purchased

Note: dental practice valuations are currently about 5x–9x EBITDA broadly and are expected to compress toward a more conservative 4x–6x over the next few years, which can make both timing and process quality increasingly important.

Pre-Market Readiness Checklist for Your Practice

The following items can help you gauge whether a practice is positioned to go to market. Gaps in any area are usually addressable, and owners often find it easier to address them before the process begins rather than during buyer diligence.

Readiness Item	Status
Three years of clean, reconciled financial statements available	Ready / In Progress / Not Started
Practice management software reports (production, collections, active patients) exportable	Ready / In Progress / Not Started
Owner compensation add-backs documented with market benchmarks	Ready / In Progress / Not Started
Lease term of at least 5 years remaining (or renewal option in place)	Ready / In Progress / Not Started
Revenue not concentrated in a single provider	Ready / In Progress / Not Started
Sell-side advisor, CPA, and healthcare attorney identified	Ready / In Progress / Not Started
Personal and transition goals clearly defined	Ready / In Progress / Not Started
Multi-year, after-tax cash-flow model comparing deal structures completed	Ready / In Progress / Not Started

Common Seller Mistakes in DSO Transitions

• Talking to one DSO first. An inbound call from a DSO does not represent the market. Responding before a competitive process is in place surrenders negotiating leverage and anchors valuation to the buyer’s number.

• Accepting a “free” valuation. A quick number set by the buyer often becomes the anchor for the entire negotiation. Reported EBITDA of $5M can undergo a 10–30% reduction during quality of earnings analysis, and a seller without a defensible, independently prepared valuation has limited basis to push back.

• Ignoring the equity component. Up to about 40% of a DSO deal can be paid in rollover equity rather than cash. That equity is illiquid, and its value depends on the DSO’s financial health and future exit. Treating the headline number as equivalent to cash at close can be a costly mistake.

• Skipping multi-year cash-flow modeling. A DSO offer, a private-buyer offer, and continued ownership can each produce different after-tax outcomes over 3, 5, and 10 years. Tax and legal structuring decisions made at least 2 years before a dental practice sale can move 15–30% of net-to-seller proceeds, so early modeling can be a practical necessity rather than a luxury.

• Underestimating the earnout risk. Earnouts in DSO transactions are often tied to future production benchmarks, while the buyer controls post-acquisition expenses, staffing, and pricing decisions. Poorly negotiated terms can shift most of the risk to the seller.

• Waiting too long to prepare financials. Preparing for due diligence can be helpful 6–12 months before going to market, because clean financial history cannot be created retroactively.

Frequently Asked Questions

How long does a DSO affiliation process typically take from start to close?

The full timeline from initial engagement with a sell-side advisor through a signed purchase agreement and wire transfer for DSO deals commonly runs 3–6 months. The competitive bid process itself, from sending marketing materials to receiving initial offers, typically takes 45–60 days. Due diligence and legal documentation after a signed Letter of Intent usually add 60–120 days, depending on deal complexity. Preparation work, including financial clean-up and valuation, often begins 6–12 months before going to market, so owners who want to close within a calendar year can benefit from starting conversations early.

What percentage of a DSO deal is typically paid in cash at close versus equity or earnout?

Deal structures can vary by buyer type and practice size, but most DSO transactions provide a meaningful portion of total consideration as cash at close, with the remainder structured as rollover equity and an earnout. Cash-at-close percentages can range widely across formal DSO acquisitions, regional roll-ups, platform private equity acquisitions, and partnership structures. As much as 40% of a deal can be paid in equity rather than cash. Because rollover equity is illiquid and its value depends on the DSO’s future performance and exit, owners can benefit from modeling the after-tax, risk-adjusted value of each component, not just the headline number. A multi-year cash-flow model built by a dental-specific advisor is often the most practical tool for that comparison.

How does McLerran & Associates protect valuation during buyer due diligence?

McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis before the practice goes to market, documenting each add-back so the numbers are defensible when a buyer’s Quality of Earnings team reviews them. During due diligence, the firm actively defends that analysis and challenges buyer adjustments that are not supported by the underlying data. Because McLerran runs a competitive process with multiple vetted buyers, it can also remind buyers, when appropriate, that other qualified bidders remain interested, which can discourage attempts to re-trade the agreed valuation near closing. This combination of up-front rigor and active defense helps McLerran maintain the high transaction rate described earlier in this article.

Should I sell to a DSO or a private buyer?

The right path can depend on your practice’s size, profitability, and personal goals. Practices generating roughly $1 million to $1.5 million in annual revenue often fit a doctor-to-doctor sale well, while the largest practices, particularly those with $3 million or more in revenue, tend to attract the strongest DSO interest and higher EBITDA-based multiples. Owners in the middle range can often pursue either path. Because McLerran & Associates works both markets in roughly equal measure, it can produce a side-by-side valuation that quantifies the practice’s worth in both the private-buyer and DSO markets, so the decision rests on real numbers rather than assumptions. The firm’s first priority is to understand your “why” before recommending any direction.

What makes a dental practice more attractive to DSO buyers?

Several factors can influence how DSO buyers evaluate and price a practice. Practices with strong associate production, meaning revenue that is not entirely dependent on the selling owner, often command stronger interest because the buyer is acquiring a durable earnings stream rather than a single provider’s production. A transferable patient base, modern infrastructure, a lease with sufficient term remaining, and a location within a DSO’s target expansion area can also be favorable. By contrast, heavy Medicaid concentration in the payer mix, production concentrated in a single provider, and short lease terms can suppress valuation. Identifying which factors apply to your practice, and addressing practical gaps before going to market, is a key goal of a comprehensive pre-market preparation process.

Next Step: Protect Your Valuation and Legacy

Owners who achieve strong outcomes in DSO transitions are not always those with the largest practices. They are often the ones who approach the process with clear goals, a defensible EBITDA analysis, a competitive bid process, and a sell-side advisor focused solely on their interests.

McLerran & Associates has evaluated more than 10,000 dental practices and closed roughly 2,000 transactions totaling about $2 billion in volume. Clients who follow a structured process with McLerran typically achieve valuations about 30% higher than owners who go it alone, while maintaining the firm’s industry-leading close rate mentioned earlier.

Whether a transition is 6 months away or 3 years away, the most practical time to understand your options and your value is before a buyer calls, not after.

Schedule a free, confidential discovery call with McLerran & Associates to discuss your practice, your goals, and how a structured sell-side process could shape your outcome. Call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com/contact-us.